Search Results

There are 10078 results for: content related to: Drug selection and timing of initiation of treatment in early Parkinson's disease

  1. Treatment of levodopa-induced motor complications

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S599–S612, Fabrizio Stocchi, Michele Tagliati and C. Warren Olanow

    Article first published online : 9 SEP 2008, DOI: 10.1002/mds.22052

  2. You have free access to this content
    Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 5–15, J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli and W. H. Oertel

    Article first published online : 22 DEC 2012, DOI: 10.1111/j.1468-1331.2012.03866.x

  3. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, Katherine Deane, van Hilten, Keith Wheatley, Richard Gray, Kelly Handley and Alex Furmston

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD007166.pub2

  4. Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1739–1752, M J Bonifácio, L Torrão, A I Loureiro, P N Palma, L C Wright and P Soares-da-Silva

    Article first published online : 20 JAN 2015, DOI: 10.1111/bph.13020

  5. Early (Uncomplicated) Parkinson's Disease

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Pages: 217–236, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch14

  6. Late (Complicated) Parkinson's Disease

    European Handbook of Neurological Management

    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio, Pages: 245–265, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch18

  7. Limitations of current Parkinson's disease therapy

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S3–S15, Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel-Courbon and Jean-Louis Montastruc

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10513

  8. Levodopa in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 16, Issue 9, September 2009, Pages: 982–989, A. H. V. Schapira, M. Emre, P. Jenner and W. Poewe

    Article first published online : 15 JUN 2009, DOI: 10.1111/j.1468-1331.2009.02697.x

  9. Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

    Movement Disorders

    Volume 26, Issue 4, March 2011, Pages: 587–598, Rebecca Stowe, Natalie Ives, Carl E. Clarke, Kelly Handley, Alexandra Furmston, Katherine Deane, J.J. van Hilten, Keith Wheatley and Richard Gray

    Article first published online : 2 MAR 2011, DOI: 10.1002/mds.23517

  10. Early (Uncomplicated) Parkinson's Disease

    European Handbook of Neurological Management

    M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol, C. Sampaio, Pages: 224–244, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch17

  11. Milestones in Parkinson's disease therapeutics

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 1072–1082, Olivier Rascol, Andres Lozano, Matthew Stern and Werner Poewe

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23714

  12. You have free access to this content
    Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease

    European Journal of Neurology

    Volume 13, Issue 11, November 2006, Pages: 1170–1185, M. Horstink, E. Tolosa, U. Bonuccelli, G. Deuschl, A. Friedman, P. Kanovsky, J. P. Larsen, A. Lees, W. Oertel, W. Poewe, O. Rascol and C. Sampaio

    Article first published online : 16 JUN 2006, DOI: 10.1111/j.1468-1331.2006.01547.x

  13. You have free access to this content
    Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 5, May 2012, Pages: 380–387, Spyridon (Spyros) Papapetropoulos

    Article first published online : 7 JUN 2011, DOI: 10.1111/j.1755-5949.2011.00253.x

  14. You have free access to this content
    Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Article first published online : 21 OCT 2014, DOI: 10.1002/mds.26050

  15. Pharmacotherapy and Treatment of Parkinson's Disease

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Wing Lok Au and Donald B. Calne

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn062

  16. Late (Complicated) Parkinson's Disease

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Pages: 237–267, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch15

  17. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Article first published online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  18. Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

    Drug Development Research

    Volume 42, Issue 1, September 1997, Pages: 1–25, Jasper Dingemanse

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-2299(199709)42:1<1::AID-DDR1>3.0.CO;2-I

  19. Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

    European Journal of Neuroscience

    Volume 37, Issue 5, March 2013, Pages: 831–838, Philippe Huot, Tom H. Johnston, Tessa Snoeren, James B. Koprich, Michael P. Hill, Susan H. Fox and Jonathan M. Brotchie

    Article first published online : 3 JAN 2013, DOI: 10.1111/ejn.12093

  20. Tolcapone, a Selective Catechol-O-Methyltransferase Inhibitor for Treatment of Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 1, January-February 1999, Pages: 6–20, David R. P. Guay

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.19.1.6.30516